A pharmacokinetic safety study to compare GTN blood plasma levels of MED2002 with existing cardiovascular GTN drugs

Trial Profile

A pharmacokinetic safety study to compare GTN blood plasma levels of MED2002 with existing cardiovascular GTN drugs

Recruiting
Phase of Trial: Phase I

Latest Information Update: 29 Nov 2017

At a glance

  • Drugs Nitroglycerin (Primary)
  • Indications Erectile dysfunction
  • Focus Pharmacokinetics
  • Most Recent Events

    • 29 Nov 2017 According to a Futura Medical media release, the first healthy subjects have already been recruited in this trial. This trial expected to be completed by the end of Q1 2018.
    • 29 Nov 2017 According to a Futura Medical media release, data from this study will determine the dosages to be used in other two Phase III trials (see profile 290892 and 283164).
    • 29 Nov 2017 According to a Futura Medical media release, the Medicines and Healthcare products Regulatory Agency and the Medicines Evaluation Board has approved this and other two Phase III trials (see profile 290892 and283164).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top